Neuren Pharmaceuticals and its US partner Acadia have been blitzing it with the Rett syndrome treatment Daybue.

Cerebral palsy (CP) continues to disproportionately affect children in low- and middle-income countries (LMICs), where neonatal hypoxic-ischemic encephalopathy (HIE ... warrants further investigation.

Therapeutic hypothermia is the only treatment shown to reduce death or disability for infants with moderate to severe hypoxic-ischaemic encephalopathy (HIE ... understanding of the neuroprotective and ...

Erythropoietin, a treatment for newborns with critically low levels of oxygen or blood supply to the brain at birth, does not prevent death or disability, according to a new multinational study.

Pune: PMC's maternal death review report on Friday cited hypoxic encephalopathy, along with lactic acidosis and and disseminated intravascular coagulation, as the cause of Tanisha alias Ishwari ...

The Company’s lead candidate, RLS-0071 (pegtarazimod), has received FDA Orphan Drug Designation and Fast Track Designations for hypoxic ischemic encephalopathy (HIE), a devastating disease that ...

By Karen Roman ReAlta Life Sciences said it is presenting new data from its hypoxic ischemic encephalopathy (HIE) program at ...

Hypoxic-ischemic encephalopathy (HIE) is one of the leading causes of newborn mortality and morbidity worldwide, and lowering the baby's body temperature—called therapeutic hypothermia—is ...